CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES USEFUL AS MODULATORS OF THE 5-HT 2A SEROTONIN RECEPTOR - Patent 4419505

(19)

(11)

EP 4 419 505 A1

(12)

(43)	Date of publication:
	28.08.2024 Bulletin 2024/35

(21)	Application number: 22800785.2

(22)	Date of filing: 19.10.2022

(51)

International Patent Classification (IPC):

C07D 239/26^(2006.01)
A61P 9/00^(2006.01)

A61K 31/506^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C07D 239/26; A61P 9/00

(86)	International application number:
	PCT/IB2022/060059

(87)	International publication number:
	WO 2023/067520 (27.04.2023 Gazette 2023/17)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

22.10.2021 US 202163270926 P

(71)	Applicant: Arena Pharmaceuticals, Inc.
	New York, NY 10001-2192 (US)

(72)	Inventors:
	BLACKBURN, Anthony C. San Diego, California 92129 (US) LIN, Jui-chen Taipei City, 104072 (TW)

(74)	Representative: Pfizer
	European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 75668 Paris Cedex 14 (FR)

(54)	CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES USEFUL AS MODULATORS OF THE 5-HT 2A SEROTONIN RECEPTOR